Visiting Worker

Research Group Home Page: 

Work address: 
Cancer Research UK Cambridge Institute University of Cambridge Li Ka Shing Centre Robinson Way Cambridge CB2 0RE

Cancer: The Tumor-Driven Disease of the Host.

E-pub date: 30 Jun 2018

A type III complement factor D deficiency: Structural insights for inhibition of the alternative pathway.

E-pub date: 06 Mar 2018

A comparative analysis of immune privilege in pregnancy and cancer in the context of checkpoint blockade immunotherapy.

E-pub date: 28 Feb 2018

Cancer Immunotherapy Trials Underutilize Immune Response Monitoring.

E-pub date: 31 Jan 2018

New Model for Estimating Glomerular Filtration Rate in Patients With Cancer.

E-pub date: 20 Aug 2017

Cancer immunotherapy trial registrations increase exponentially but chronic immunosuppressive glucocorticoid therapy may compromise outcomes.

E-pub date: 01 Jul 2017

Connecting the Metabolic and Immune Responses to Cancer.

E-pub date: 31 May 2017

A molecular and preclinical comparison of the PD-1-targeted T-cell checkpoint inhibitors nivolumab and pembrolizumab.

E-pub date: 01 Apr 2017

Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity.

E-pub date: 08 Nov 2016

Chemotherapy vs supportive care alone for relapsed gastric, gastroesophageal junction, and oesophageal adenocarcinoma: a meta-analysis of patient-level data.

E-pub date: 16 Feb 2016

Prostatic relapse of an undifferentiated teratoma 24 years after orchidectomy.

E-pub date: 01 Oct 2015

The use of error-category mapping in pharmacokinetic model analysis of dynamic contrast-enhanced MRI data.

E-pub date: 01 Feb 2015

Cross-sectional analysis of data from the U.S. clinical trials database reveals poor translational clinical trial effort for traumatic brain injury, compared with stroke.

E-pub date: 31 Aug 2014

Cross-sectional and longitudinal analysis of cancer vaccination trials registered on the US Clinical Trials Database demonstrates paucity of immunological trial endpoints and decline in registration since 2008.

E-pub date: 31 Aug 2014

Panhypopituitarism secondary to a solitary hypothalamic metastasis.

E-pub date: 23 May 2014

Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial.

E-pub date: 31 Jan 2014

Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer.

E-pub date: 10 Dec 2013

Adjuvant therapy in renal cell carcinoma-past, present, and future.

E-pub date: 31 Aug 2013

Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD.

E-pub date: 30 Oct 2012

The future of adjuvant therapy for renal cell carcinoma

E-pub date: 30 Jun 2012

Biopharmaceuticals and monoclonal antibodies in oncology trials–a cross-sectional analysis.

E-pub date: 31 Jan 2011

Exploring new routes for neuroprotective drug development in traumatic brain injury.

E-pub date: 14 Apr 2010

Designing a metal-binding site in the scaffold of Escherichia coli KDO8PS.

E-pub date: 01 Apr 2004

Characterization of the calcium-release channel/ryanodine receptor from zebrafish skeletal muscle.

E-pub date: 30 Sep 2001

Conservation of localization patterns of IP(3) receptor type 1 in cerebellar Purkinje cells across vertebrate species.

E-pub date: 31 Aug 2000

Show all